Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Girolamo Pelaia"'
Autor:
Gianenrico Senna, Maria Aliani, Elena Altieri, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Paolo Cameli, Giorgio Walter Canonica, Cristiano Caruso, Maria D'Amato, Fausto De Michele, Stefano Del Giacco, Fabiano Di Marco, Francesco Menzella, Girolamo Pelaia, Paola Rogliani, Micaela Romagnoli, Pietro Schino, Jan Walter Schroeder, Alessandra Vultaggio, Sara Rizzoli, Alessandro Zullo, Silvia Boarino, Marilena Palmisano, Alessandra Rossi, Gianfranco Vitiello, Stefano Centanni
Publikováno v:
Journal of Asthma and Allergy. 15:1593-1604
Gianenrico Senna,1,2 Maria Aliani,3 Elena Altieri,4 Pietro Bracciale,5 Luisa Brussino,6 Maria Filomena Caiaffa,7 Paolo Cameli,8 Giorgio Walter Canonica,9,10 Cristiano Caruso,11 Maria DâAmato,12 Fausto De Michele,13 Stefano Del Giacco,14 Fabiano
Autor:
M D'Amato, Giovanna Elisiana Carpagnano, Emanuela Resta, Nunzio Crimi, Massimiliano Povero, Girolamo Pelaia, Cecilia Calabrese, Onofrio Resta, Corrado Pelaia, Nicola Scichilone, Giulia Scioscia, Maria Pia Foschino Barbaro
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports
Scientific Reports
Severe asthma is burdened by frequent exacerbations and use of oral corticosteroids (OCS), which worsen patients’ health and increase healthcare spending. The aim of this study was to assess the clinical and economic impact of switching from omaliz
Autor:
Corrado Pelaia, Andrea Rizzi, Luisa Ricciardi, Claudia Crimi, Stefano Andaloro, Girolamo Pelaia, Nunzio Crimi, Ornella Bonavita, Giuseppe Valenti, Paolo Morini, Nicola Scichilone
INTRODUCTION Asthma symptoms can be relieved through a maintenance treatment combining long-acting β2-agonist and inhaled corticosteroids (LABA/ICS). However, for patients with inadequately controlled asthma, the LABA/ICS combination might not be su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f92f0cc37e727cebf3a46a2cad078f23
https://hdl.handle.net/20.500.11769/548302
https://hdl.handle.net/20.500.11769/548302
Autor:
Giuseppe Valenti, Domenico Ciotta, Simona Pellegrino, Corrado Pelaia, Nunziata Ribecco, Nunzio Crimi, Girolamo Pelaia, Alessandro Vatrella, Alida Benfante, Angela Maria D'Uggento, Giulia Scioscia, Danilo Di Bona, Luigi Macchia, Maria Filomena Caiaffa, Giovanna Elisiana Carpagnano, Claudia Crimi, Cecilia Calabrese, Raffaele Campisi, Nicola Scichilone, Giuseppe Spadaro, Maria D'Amato
Background: Benralizumab is effective in severe eosinophilic asthma (SEA), but suboptimal responses are observed in some patients. Although several factors have been associated with benralizumab response, no cluster analysis has yet been undertaken t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1735e2213a547239e34d66116bfef264
http://hdl.handle.net/10447/541238
http://hdl.handle.net/10447/541238
Autor:
Valentina Trimarco, Raffaele Izzo, Alessandro Zanforlin, Francesco Tursi, Francesco Scarpelli, Pierachille Santus, Alfio Pennisi, Girolamo Pelaia, Chiara Mussi, Simone Mininni, Nunzia Messina, Giuseppe Marazzi, Mauro Maniscalco, Mario Mallardo, Giovanni Fazio, Antonio Diana, Massimo Capra Marzani, Teresita Aloè, Pasquale Mone, Bruno Trimarco, Gaetano Santulli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cb3a0fe127f0ccaf73c25ada8435e5f
https://hdl.handle.net/11695/120671
https://hdl.handle.net/11695/120671
Autor:
Harrison, Tim W, Chanez, Pascal, Menzella, Francesco, Canonica, Giorgio Walter, Louis, Renaud, Cosio, Borja G, Lugogo, Njira L, Mohan, Arjun, Burden, Annie, McDermott, Lawrence, Garcia Gil, Esther, Zangrilli, James G, Wolfgang Pohl, Robert Voves, Maud Deschampheleire, Renaud Louis, Jean-Benoit Martinot, Rudi Peché, Kenneth Chapman, Amarjit Cheema, Delbert Dorscheid, J Mark FitzGerald, Remi Gagnon, William Patrick Killorn, Ronald Olivenstein, George Philteos, Clare Ramsey, J Douglass Rolf, Brandie Walker, Ole Hilberg, Tina Skjold, Ingrid Titlestad, Auli Hakulinen, Maritta Kilpeläinen, Michèle Ben Hayoun, Philippe Bonniaud, Arnaud Bourdin, Pascal Chanez, Frédéric De Blay, Gaëtan Deslee, Gilles Devouassoux, Alain Didier, Youcef Douadi, Stéphanie Fry, Gilles Garcia, Pierre-Olivier Girodet, Christophe Leroyer, Antoine Magnan, Guillaume Mahay, Cécilia Nocent, Christophe Pison, Pauline-Marie Roux, Camille Taillé, Juliana-Angelica Tiotiu, Ekkehard Beck, Margret Jandl, Christian Kaehler, Frank Kässner, Frank Koesters, Juliane Kronsbein, Thomas Schaum, Christian Schulz, Dirk Skowasch, Christian Taube, Tobias Welte, Andrés de Roux, Bianca Beghé, Francesco Blasi, Giorgio Walter Canonica, Giovanna Carpagnano, Cristiano Caruso, Angelo Guido Corsico, Elio Constantino, Nunzio Crimi, Piero Maestrelli, Francesco Menzella, Manlio Milanese, Alberto Papi, Girolamo Pelaia, Laura Pini, Pierachille Santus, Eleonora Savi, Nicola Scichilone, Gianenrico Senna, Giuseppe Spadaro, Adriano Vaghi, Steven Gans, Jurgen Hölters, B Langeveld, Willem Pieters, G H A Staaks, Ilonka van Veen, J W K van den Berg, Gunnar Einvik, Sverre Lehmann, Ismael Ali García, Carlos Almonacid, Irina Bobolea, Paloma Campo Mozo, Gustavo de Luiz, Christian Domingo Ribas, José María Echave-Sustaeta María-Tomé, Juan Luis García Rivero, Borja García-Cosío Piqueras, Ana Gómez-Bastero Fernández, Ruperto González Pérez, Aythamy Henríquez Santa, Carlos Martínez Rivera, Xavier Muñoz Gall, Jacinto Ramos, Jose Gregorio Soto Campos, Carmen Vidal Pan, Nikolai Stenfors, Alf Tunsäter, Ines Vinge, Rekha Chaudhuri, Timothy Harrison, Adel Mansur, Shuaib Nasser, Monica Nordstrom, Paul Pfeffer, Dinesh Saralaya, Philip Short, Arun Adlakha, Oral Alpan, Francis Averill, Anil Badhwar, Jose Bardelas, Barbara Baxter, George Bensch, William Berger, Jonathan Bernstein, Tracy Bridges, Ryan Brimeyer, William Calhoun, Edward Campbell, William Brett Cherry, Geoffrey Chupp, Lee Clore, John Cohn, Jeremy Cole, John Condemi, James Cury, Benjamin Davis, Samuel DeLeon, Luis Delacruz, Joseph Diaz, David Erb, Emeka Eziri, Faisal Fakih, Douglas Fiedler, David Fost, Stephen Fritz, Erika Gonzalez, Brad Goodman, Peter Gottlieb, Gregory Gottschlich, Richard Gower, Rizan Hajal, James Harris, Hengameh Heidarian-Raissy, Albrecht Heyder, David Hill, Fernando Holguin, Iftikhar Hussain, Jonathan Illowite, Joshua Jacobs, Mikell Jarratt, Harold Kaiser, Neil Kao, Ravindra Kashyap, David Kaufman, Edward Kent, Kenneth Kim, Ryan Klein, Monica Kraft, Ritsu Kono, Shahrukh Kureishy, Jeffrey Leflein, Mila Leong, Huamin Li, Robert Lin, Njira Lugogo, Michael Marcus, Diego Jose Maselli Caceres, Vinay Mehta, Curtis Mello, Mark Millard, Aaron Milstone, Arjun Mohan, Wendy Moore, Mark Moss, Nayla Mumneh, Thomas O'Brien, David Ostransky, Michael Palumbo, Purvi Parikh, Sudhir Parikh, Amit Patel, Guido Perez, Warren Pleskow, Bruce Prenner, Dileep Puppala, John Ramey, Joan Reibman, Ramon Reyes, Emory Robinette, Ileana Rodicio, Stephen Ryan, Sudhir Sekhsaria, Barry Sigal, Vinay Sikand, Weily Soong, Selwyn Spangenthal, Roy St John, Gary Steven, Vijay Subramaniam, Kaharu Sumino, Eric Sztejman, Ricardo A Tan, Tonny Tanus, Charles Thompson, Carl Thornblade, Manuel Villareal, Sally Wenzel, Heidi Zafra, Tomasz Ziedalski
Publikováno v:
The Lancet Respiratory Medicine
The Lancet Respiratory Medicine, Elsevier, 2021, 9 (3), pp.260-274. ⟨10.1016/S2213-2600(20)30414-8⟩
The Lancet. Respiratory medicine, Vol. 9, no. 3, p. 260-274 (2021)
The Lancet Respiratory Medicine, Elsevier, 2021, 9 (3), pp.260-274. ⟨10.1016/S2213-2600(20)30414-8⟩
The Lancet. Respiratory medicine, Vol. 9, no. 3, p. 260-274 (2021)
Background: ANDHI was done to assess the efficacy of benralizumab, including onset of effect and impact on health-related quality of life (HRQOL), exacerbation rate, lung function, and nasal polyposis symptoms. Methods: This phase 3b, randomised, dou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7980c098e2b8b43a3561652584e4867
https://hal.univ-reims.fr/hal-03170335
https://hal.univ-reims.fr/hal-03170335
Autor:
Giovanna Elisiana Carpagnano, Nicola Scichilone, Luigi Macchia, Alida Benfante, Claudia Crimi, Simona Pellegrino, Santi Nolasco, Giuseppe Spadaro, Alessandro Vatrella, Giuseppe Valenti, Giulia Scioscia, Maria D'Amato, Maria Filomena Caiaffa, Corrado Pelaia, Cecilia Calabrese, Domenico Ciotta, Girolamo Pelaia, Nunzio Crimi
Publikováno v:
Journal of Asthma and Allergy
Journal of Asthma and Allergy, Vol Volume 14, Pp 163-173 (2021)
Journal of Asthma and Allergy, Vol Volume 14, Pp 163-173 (2021)
Corrado Pelaia,1 Claudia Crimi,2 Alida Benfante,3 Maria Filomena Caiaffa,4 Cecilia Calabrese,5 Giovanna Elisiana Carpagnano,6 Domenico Ciotta Jnr,7 Maria D’Amato,8 Luigi Macchia,9 Santi Nolasco,2 Girolamo Pelaia,1 Simona Pellegrino,7 Nicola Scichil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d9ecfd37e9ccb22fe44100c39068c03
http://hdl.handle.net/11591/458968
http://hdl.handle.net/11591/458968
Autor:
Giuseppe Valenti, Giovanna Elisiana Carpagnano, Simona Pellegrino, Domenico Ciotta, Alida Benfante, Corrado Pelaia, Maria Filomena Caiaffa, Nunzio Crimi, Girolamo Pelaia, Santi Nolasco, Raffaele Campisi, Luigi Macchia, Claudia Crimi, Giuseppe Spadaro, Maria D'Amato, Nicola Scichilone, Cecilia Calabrese, Alessandro Vatrella, Giulia Scioscia
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 9:4371-4380.e4
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) affects around 60% of patients with severe eosinophilic asthma (SEA). Benralizumab was recently approved for SEA add-on treatment. Objective: To assess the real-world effectiveness of benr
Autor:
Girolamo Pelaia, Nicola Scichilone, Onofrio Resta, Carla Maria Irene Quarato, Giulia Scioscia, Corrado Pelaia, Nunzio Crimi, Giovanna Elisiana Carpagnano, Maria Pia Foschino Barbaro, Maria D'Amato, Cecilia Calabrese
Publikováno v:
Therapeutic Advances in Respiratory Disease
Therapeutic Advances in Respiratory Disease, Vol 14 (2020)
Therapeutic Advances in Respiratory Disease, Vol 14 (2020)
Background: Current availability of several biologic treatments for severe asthma makes it possible to choose the most appropriate for each patient. Sometimes a good percentage of patients with severe asthma may be eligible for biologics that target
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1926b7e25b7207a50eeccca0748a7833
http://hdl.handle.net/11591/472189
http://hdl.handle.net/11591/472189
Autor:
Pierluigi Paggiaro, Fulvio Braido, A. Gentile, Federico Lavorini, A. Soldi, V. Pegoraro, Nicola Scichilone, F. Di Marco, Paola Rogliani, Girolamo Pelaia, G.W. Canonica, A. Bianco, Angelo Corsico, Pierachille Santus, Francesco Blasi
Background The choice of inhaler device for asthma patients depends upon multiple attributes. We investigated factors that may drive general practitioners (GPs) and respiratory specialists in the prescription of inhaler devices for asthma patients wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e48904182d2f57d265270b03c2077df
http://hdl.handle.net/11567/1026082
http://hdl.handle.net/11567/1026082